773 research outputs found
More than 10 years of experience with immediate sequential bilateral cataract extraction (ISBCE) - a retrospective study
Background: To evaluate the safety of immediate sequential bilateral cataract extraction (ISBCE)
with respect to indications, visual outcomes, complications, benefits and disadvantages. Methods:
This is a retrospective review of all ISBCEs performed at Kantonsspital Winterthur, Switzerland,
between April 2000 and September 2013. The case notes of 500 eyes of 250 patients were reviewed.
Of these 500 eyes, 472 (94.4%) had a straight forward phacoemulsification with posterior
chamber intraocular lens implantation; 21 (4.2%) had a planned extracapsular cataract extraction;
4 (0.8%) had an intracapsular cataract extraction and 3 (0.6%) had a combined phacoemulsification
with trabeculectomy. Results: Over 66% of eyes achieved improved visual acuity (at least 3
Snellen lines) following ISBCE. Median preoperative best corrected visual acuity (BCVA) was 0.5
LogMAR; the interquartile range was [0.4, 1] LogMAR. At one week control the median BCVA was
0.3 LogMAR, IQR [0.1, 0.5] LogMAR. At one month the median BCVA was 0.15 LogMAR, IQR [0.05,
0.3] (p < 0.01). There were no sight-threatening intraoperative or postoperative complications
observed. Conclusions: ISBCE is an effective and safe option with high degree of patient satisfaction.
The relative benefits of ISBCE should be balanced against the theoretically enhanced risks
OkulÀre Pulsamplitude als biometrischer Messwert in der Glaukomdiagnostik
Zusammenfassung: Hintergrund: Die dynamische Konturtonometrie (DCT) ermöglicht direkte transkorneale Messungen des Augeninnendrucks und der okulĂ€ren Pulsamplitude (OPA). Ziel dieser Studie war es, herauszufinden, ob die OPA als biometrischer Messwert Aussagen ĂŒber verschiedene Glaukomformen erlaubt. Patienten und Methoden: Es wurden 441 Augen von 222Patienten in die Studie aufgenommen. Zur Druckmessung dienten die DCT und ein Applanationstonometer nach Goldmann. Ergebnisse: Die mittlere OPA betrug 3,1±1,4mmHg. Augen mit okulĂ€rer Hypertension (3,6±1,3mmHg) zeigten signifikant höhere Werte als gesunde Augen (3,1±1,4mmHg) und solche mit Niederdruckglaukom (2,9±1,4mmHg). Nach erfolgreicher Trabekulektomie wurden signifikant tiefere Werte (2,4±1,3mmHg) als bei Gesunden gemessen. Schlussfolgerung: Die OPA scheint diverse Formen des Glaukoms zu charakterisieren, könnte aber auch direkt von der Höhe des Augendrucks abhĂ€ngen. Es muss weiter abgeklĂ€rt werden, ob sie einen prĂ€diktiven Faktor in der Diagnose und der Verlaufsbeurteilung des Glaukoms darstell
How mycorrhizal associations and plant density influence intra- and inter-specific competition in two tropical tree species: Cabralea canjerana (Vell.) Mart. and Lafoensia pacari A.St.-Hil.
Arbuscular mycorrhizal fungi (AMF) associations benefit host plants due to increased ability to obtain resources and hence may influence competitive interactions. Here we experimentally examine growth in Cabralea canjerana and Lafoensia pacari at different densities and with and without AMF. In the density treatment pots had either six or 12 individuals. Half of each treatment was innoculated with AMF and the other half was not. The proportion of each species in each pot was also varied. The AMF did not apparently influence interspecific competitive interactions because growth was similar in both treatments. However, intra-specific competition was very strong in C. canjerana while more moderate in L. pacari and both were influenced by the presence of the AMF. The AMF?Cabralea canjerana interaction was parasitic, while AMF?L. pacari interactions were mutualistic. Thus, dependence upon AMF and intraspecific interactions that result as a consequence of that dependence varies among species and may be an important influence in community structure.Publicação somente on-line
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example
BACKGROUND: The High-Dimensional Propensity Score (hd-PS) algorithm can select and adjust for baseline confounders of treatment-outcome associations in pharmacoepidemiologic studies that use healthcare claims data. How hd-PS performance is affected by aggregating medications or medical diagnoses has not been assessed. METHODS: We evaluated the effects of aggregating medications or diagnoses on hd-PS performance in an empirical example using resampled cohorts with small sample size, rare outcome incidence, or low exposure prevalence. In a cohort study comparing the risk of upper gastrointestinal complications in celecoxib or traditional NSAIDs (diclofenac, ibuprofen) initiators with rheumatoid arthritis and osteoarthritis, we (1) aggregated medications and International Classification of Diseases-9 (ICD-9) diagnoses into hierarchies of the Anatomical Therapeutic Chemical classification (ATC) and the Clinical Classification Software (CCS), respectively, and (2) sampled the full cohort using techniques validated by simulations to create 9,600 samples to compare 16 aggregation scenarios across 50% and 20% samples with varying outcome incidence and exposure prevalence. We applied hd-PS to estimate relative risks (RR) using 5 dimensions, predefined confounders, †500 hd-PS covariates, and propensity score deciles. For each scenario, we calculated: (1) the geometric mean RR; (2) the difference between the scenario mean ln(RR) and the ln(RR) from published randomized controlled trials (RCT); and (3) the proportional difference in the degree of estimated confounding between that scenario and the base scenario (no aggregation). RESULTS: Compared with the base scenario, aggregations of medications into ATC level 4 alone or in combination with aggregation of diagnoses into CCS level 1 improved the hd-PS confounding adjustment in most scenarios, reducing residual confounding compared with the RCT findings by up to 19%. CONCLUSIONS: Aggregation of codes using hierarchical coding systems may improve the performance of the hd-PS to control for confounders. The balance of advantages and disadvantages of aggregation is likely to vary across research settings
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
AimsâDipeptidyl-peptidase-4 inhibitors (DPP-4i) have been implicated with an increased pancreatic cancer risk. We therefore compared pancreatic cancer incidence and diagnostic work-up among initiators of DPP-4i versus sulfonylureas (SU) and thiazolidinediones (TZD). MethodsâMedicare claims data were examined in a new-user active-comparator cohort study. Patients >65 years with no prescriptions for DPP-4i, SU or TZD at baseline were included if they had at least two claims for the same drug within 180 days. Using an as-treated approach and propensity score-adjusted Cox models, we estimated hazard ratios (HR) and 95% confidence intervals (CI) for pancreatic cancer. Diagnostic work-up was compared using risk ratios (RR). RESULTSâIn the DPP-4i vs SU comparison, there were 18,179 DPP4i initiators of which 26 developed pancreatic cancer (follow-up time interquartile range 5â18 months). In the DPP-4i vs TZD comparison there were 29,366 DPP-4i initiators and 52 developed pancreatic cancer. The hazard of pancreatic cancer with DPP-4i was lower relative to SU (HR=0.6, CI 0.4â0.9) and similar to TZD (HR=1.0, CI 0.7â1.4). Excluding first 6 months of follow-up to reduce the potential for reverse causality did not alter results. Probability of diagnostic work-up post-initiation among DPP-4i initiators (79.3%) was similar to TZD (74.1%) (RR=1.06, CI 1.05â1.07) and SU (74.6%) (RR=1.06, CI1.05â1.07). The probability of diagnostic workup pre-index was ~80% for all cohorts. ConclusionâThough limited by sample size and the observed duration of treatment in the US, our well-controlled population based study suggests no increased short-term pancreatic cancer risk with DPP-4i relative to SU or TZD
The âDry-Runâ Analysis: A Method for Evaluating Risk Scores for Confounding Control
A propensity score (PS) model's ability to control confounding can be assessed by evaluating covariate balance across exposure groups after PS adjustment. The optimal strategy for evaluating a disease risk score (DRS) model's ability to control confounding is less clear. DRS models cannot be evaluated through balance checks within the full population, and they are usually assessed through prediction diagnostics and goodness-of-fit tests. A proposed alternative is the "dry-run" analysis, which divides the unexposed population into "pseudo-exposed" and "pseudo-unexposed" groups so that differences on observed covariates resemble differences between the actual exposed and unexposed populations. With no exposure effect separating the pseudo-exposed and pseudo-unexposed groups, a DRS model is evaluated by its ability to retrieve an unconfounded null estimate after adjustment in this pseudo-population. We used simulations and an empirical example to compare traditional DRS performance metrics with the dry-run validation. In simulations, the dry run often improved assessment of confounding control, compared with the C statistic and goodness-of-fit tests. In the empirical example, PS and DRS matching gave similar results and showed good performance in terms of covariate balance (PS matching) and controlling confounding in the dry-run analysis (DRS matching). The dry-run analysis may prove useful in evaluating confounding control through DRS models
Bend it like Beckham: embodying the motor skills of famous athletes.
Observing an action activates the same representations as does the actual performance of the action. Here we show for the first time that the action system can also be activated in the complete absence of action perception. When the participants had to identify the faces of famous athletes, the responses were influenced by their similarity to the motor skills of the athletes. Thus, the motor skills of the viewed athletes were retrieved automatically during person identification and had a direct influence on the action system of the observer. However, our results also indicated that motor behaviours that are implicit characteristics of other people are represented differently from when actions are directly observed. That is, unlike the facilitatory effects reported when actions were seen, the embodiment of the motor behaviour that is not concurrently perceived gave rise to contrast effects where responses similar to the behaviour of the athletes were inhibited
Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study
Frailty, a poorly measured confounder in older patients, can promote treatment in some situations and discourage it in others. This can create unmeasured confounding and lead to nonuniform treatment effects over the propensity score (PS). The authors compared bias and mean squared error for various PS implementations under PS trimming, thereby excluding persons treated contrary to prediction. Cohort studies were simulated with a binary treatment T as a function of 8 covariates X. Two of the covariates were assumed to be unmeasured strong risk factors for the outcome and present in persons treated contrary to prediction. The outcome Y was simulated as a Poisson function of T and all Xâs. In analyses based on measured covariates only, the range of PS's was trimmed asymmetrically according to the percentile of PS in treated patients at the lower end and in untreated patients at the upper end. PS trimming reduced bias due to unmeasured confounders and mean squared error in most scenarios assessed. Treatment effect estimates based on PS range restrictions do not correspond to a causal parameter but may be less biased by such unmeasured confounding. Increasing validity based on PS trimming may be a unique advantage of PS's over conventional outcome models
Tamoxifen Initiation After Ductal Carcinoma In Situ
Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone. We evaluated endocrine therapy use after DCIS over a 15-year period in an integrated health care setting to identify factors related to initiation
- âŠ